Earnings call: FibroGen reports Q1 2024 results, optimistic about pipeline By Investing.com

Published on 7 May 2024 on Investing.com

FibroGen, Inc. (NASDAQ:FGEN) has reported its financial results for the first quarter of 2024,...

Read the rest of the article

Start tracking your investments with Statfolio

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. · via Yahoo Finance 19 Jun 2024

FibroGen, Inc. FGEN shares are trading higher Tuesday after the company posted mixed first-quarte...

Benzinga 7 May 2024

FibroGen, Inc. (NASDAQ:FGEN) has reported its financial results for the first quarter of 2024,...

Investing.com 7 May 2024

FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses o...

Insider Monkey via Yahoo Finance 7 May 2024

Shares of Beyond, Inc. BYON fell sharply during Tuesday’s session following weaker-than-expected ...

Benzinga 7 May 2024

Cardiff Oncology, Inc. CRDF is developing novel therapeutic candidates to treat various types of ...

Zacks via Yahoo Finance 21 Mar 2024

Crinetics Pharmaceuticals’ CRNX shares gained 19.1% on Mar 19 after the company reported positive...

Zacks via Yahoo Finance 20 Mar 2024

Sensible investors can identify potential issues from declining financial reports, brewing servic...

InvestorPlace 20 Mar 2024

Mirum Pharmaceuticals, Inc. MIRM announced that the FDA had approved a label expansion for Livmar...

Zacks via Yahoo Finance 15 Mar 2024

AstraZeneca AZN announced that it has entered into a definitive agreement to acquire Amolyt Pharm...

Zacks via Yahoo Finance 14 Mar 2024